Find your path to Ugur
76 people in our graph can introduce you to Ugur.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Sophia Lai to introduce you to Ugur
You →Sophia · together at Voro Therapeutics (2023–2026) →Ugur
Ask Jamie Chen to introduce you to Ugur
You →Jamie · 3 people · together at Voro Therapeutics →Ugur
Ask Sam Okafor to introduce you to Ugur
You →Sam · 2 people · together at Janux Therapeutics →Ugur
Sign up to find every way you can get introduced to Ugur
- Your email: the people you already email who know Ugur
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Ugur
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Ugur Eskiocak is CEO and Co-Founder of Voro Therapeutics. He is a cancer biologist with experience in immuno-oncology, molecular biology, genome editing, and high throughput screening, with expertise spanning pre-clinical efficacy studies, drug development, IND-enabling studies, and Phase 1 clinical trials. He has led cross-functional research teams in both academic and industrial settings and holds project management certification.
Experience
- Voro TherapeuticsCEO & Co-Foundercurrent2023 — present
- Alloy Therapeutics, Inc.Entrepreneur In Residence2022 — 2024
- Janux TherapeuticsSenior Director, Translational Sciences2021 — 2022
- TakedaTranslational Strategy Lead, Immuno-Oncology2020 — 2021
- Xilio Therapeutics, Inc.Director of In Vivo Pharmacology2019 — 2020
- Compass Therapeutics LLCAssociate Director, In Vivo Immunopharmacology2018 — 2019
- Compass Therapeutics LLCSenior Scientist, Group Leader – In Vivo Immunopharmacology2017 — 2018Greater Boston
- Compass Therapeutics LLCScientist II2016 — 2017Greater Boston
- Children's Research Institute at UT SouthwesternPostdoctoral Scientist - Lab of Sean J Morrison2011 — 2016Dallas, TX
- Children's Research Institute at UT SouthwesternGraduate Research Student - Lab of Jerry W Shay & Woodring E Wright2007 — 2011Dallas, TX
- Middle East Technical UniversityMasters Research Student2006 — 2007Bursa, Türkiye
- OBITEKResearcher & Salesman2004 — 2007Bursa, Türkiye
Skills & more
+10 more
Genetic EngineeringWestern BlottingFlow CytometryFACSImmunohistochemistryImmunocytochemistryConfocal MicroscopyPCRMolecular CloningSequencingLanguages English · Turkish
- MSc — Middle East Technical University
- PhD — UT Southwestern Careers
From Ugur's professional profile.
Colleagues at 82VS
Frequently asked questions
- Who is Ugur Eskiocak?
- Ugur Eskiocak is CEO and Co-Founder of Voro Therapeutics. He is a cancer biologist with experience in immuno-oncology, molecular biology, genome editing, and high throughput screening, with expertise spanning pre-clinical efficacy studies, drug development, IND-enabling studies, and Phase 1 clinical trials. He has led cross-functional research teams in both academic and industrial settings and holds project management certification.
- Where does Ugur Eskiocak work?
- Ugur Eskiocak is Founder / EIR at 82VS.
- Where did Ugur Eskiocak go to school?
- Ugur Eskiocak studied at UT Southwestern Medical Center (Doctor of Philosophy (Ph.D.), Cancer Biology); Orta Doğu Teknik Üniversitesi / Middle East Technical University (Master’s Degree, Biology); Orta Doğu Teknik Üniversitesi / Middle East Technical University (Bachelor’s Degree, Molecular Biology and Genetics).
Same school
Also attended UT Southwestern Medical Center22
+ 16 more
Also attended Orta Doğu Teknik Üniversitesi / Middle East Technical University77
+ 71 more
Shared employers
Also worked at Voro Therapeutics4
Also worked at Alloy Therapeutics, Inc.24
+ 18 more
Also worked at Takeda90
+ 84 more
Also worked at Xilio Therapeutics, Inc.10
+ 4 more
























)




















